Aclaris Therapeutics (ACRS) Inventory (2018 - 2019)
Aclaris Therapeutics' (ACRS) quarterly Inventory came in at $189000.0 in Q3 2019, down 81.9% year-on-year from $1.0 million in Q3 2018, and up 2.16% quarter-over-quarter from $185000.0 in Q2 2019.
Aclaris Therapeutics (ACRS) Inventory (2018 - 2019) Analysis & Trends
Aclaris Therapeutics' Inventory history runs 2 years deep, the most recent figure standing at $189000.0 for Q3 2019.
- On a quarterly basis, Inventory fell 81.9% year-over-year to $189000.0 in Q3 2019; TTM through Sep 2019 was $189000.0, a 81.9% decrease from a year earlier, with the FY2018 full-year figure at $791000.0, changed N/A from the prior year.
- Inventory climbed to $189000.0 in Q3 2019 per ACRS's latest filing, from $185000.0 in the prior quarter.
- Across five years, Inventory topped out at $1.0 million in Q3 2018 and bottomed at $185000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 189,000.00 |
| Jun 30, 2019 | 185,000.00 |
| Mar 31, 2019 | 856,000.00 |
| Dec 31, 2018 | 791,000.00 |
| Sep 30, 2018 | 1.04 Mn |
| Jun 30, 2018 | 1.03 Mn |